Ceres Ventures, Inc. - FORM 10-Q - EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 USC. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - August 15, 2011

Attached files

file filename
10-Q - QUARTERLY REPORT - Ceres Ventures, Inc.v231155_10q.htm
EXCEL - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.Financial_Report.xls
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13(A)-14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - Ceres Ventures, Inc.v231155_ex31-1.htm
 
Exhibit 32.1
 
CERTIFICATION PURUSANT TO 18 U.S.C. 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PhytoMedical Technologies, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2011 as filed with the Securities and Exchange Commission on August 15, 2011 (the “Report”), I, Amit S. Dang, President, Chief Executive Officer, Chief Financial Officer, and a director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)         The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)         The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

       
Date:  August 15, 2011
 
 By: /s/ Amit S. Dang  
   
Amit S. Dang
  
   
President, Chief Executive Officer,
Chief Financial Officer, Director
  
       
 
 
 
 

Ceres Ventures, Inc. Reports